There are several concurrent problems - too many service...

There are several concurrent problems - too many service providers paid in script and seed investors were in the mix - very flight once a liquidity event materialises. It's a nightmare having a large share float with a lot of small stakeholders wanting to exit ... it's like a fire in a movie theater and there is only one door at the back ... ouch.

Next thing, is the IPO pricing was too rich - and the timing was awful. Add these two factors together, and 50% down.

That's history, so what next. If you are p1ssed off, sell and move on which is what I did during June and got a nice tax loss to off set some lithium gains.

However, I bought back at low 7s as the sales momentum is actually pretty good - and with new products and distribution channels opening up, this momentum good re-rate quite strongly over the next 12 months, especially with Priceline now a distributor.

I don't expect management to buy stock on market but take options is a good sign, and be at the coal face growing the business is paramount.

My wife is using their products for skin issues and noticed a huge improvement - she is now a big fan, as she'd tried everything under the sun.

I'm giving these guys another go.